BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 15018397)

  • 21. Molecular pathogenesis of chronic myeloid leukaemia.
    Smith DL; Burthem J; Whetton AD
    Expert Rev Mol Med; 2003 Nov; 5(27):1-27. PubMed ID: 14987402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Report of 34 patients with clonal chromosomal abnormalities in Philadelphia-negative cells during imatinib treatment of Philadelphia-positive chronic myeloid leukemia.
    Terre C; Eclache V; Rousselot P; Imbert M; Charrin C; Gervais C; Mozziconacci MJ; Maarek O; Mossafa H; Auger N; Dastugue N; Talmant P; Van den Akker J; Leonard C; N'Guyen Khac F; Mugneret F; Viguié F; Lafage-Pochitaloff M; Bastie JN; Roux GL; Nicolini F; Maloisel F; Vey N; Laurent G; Recher C; Vigier M; Yacouben Y; Giraudier S; Vernant JP; Salles B; Roussi J; Castaigne S; Leymarie V; Flandrin G; Lessard M;
    Leukemia; 2004 Aug; 18(8):1340-6. PubMed ID: 15190256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Ph-negative chronic myeloid leukemia with a complex BCR/ABL rearrangement and a t(6;9)(p21;q34.1).
    Todorić-Zivanović B; Marisavljević D; Surace C; Cemerikić V; Marković O; Krtolica K; Tatomirović Z; Cikota B; Magić Z; Rocchi M
    Cancer Genet Cytogenet; 2006 Apr; 166(2):180-5. PubMed ID: 16631477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular analysis of Philadelphia chromosome positive leukaemias.
    Young BD
    Br J Cancer Suppl; 1988 Dec; 9():58-61. PubMed ID: 3076066
    [No Abstract]   [Full Text] [Related]  

  • 25. Chronic myelocytic leukemia--Part I: History, clinical presentation, and molecular biology.
    Randolph TR
    Clin Lab Sci; 2005; 18(1):38-48. PubMed ID: 15747785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
    Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
    Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absence in Ph-negative, M-BCR rearrangement-positive chronic myelogenous leukemia of linkage between 5' ABL and 3' M-BCR sequences in Philadelphia translocation.
    Nishigaki H; Misawa S; Inazawa J; Abe T
    Leukemia; 1992 May; 6(5):385-92. PubMed ID: 1593904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Possible evidence for acquired genetic activity at both chromosomal breakpoints of the Philadelphia translocation in chronic myeloid leukemia.
    Yamada T; Secker-Walker LM
    Leukemia; 1990 May; 4(5):341-4. PubMed ID: 2388479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p190 bcr-abl rearrangement: a secondary cytogenetic event in some chronic myeloid disorders?
    Roumier C; Daudignon A; Soenen V; Dupriez B; Wetterwald M; Lai JL; Cosson A; Fenaux P; Preudhomme C
    Haematologica; 1999 Dec; 84(12):1075-80. PubMed ID: 10586207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Philadelphia-negative chronic myelogenous leukemia in a patient with a unique complex translocation: 46,XY,t(9;12;15)(q34;12;q21).
    Shanske AL; Grunwald H; Cook P; Heisterkamp N; Groffen J
    Leuk Res; 1998 Jul; 22(7):645-8. PubMed ID: 9680116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Presence of t(1;14)(p13;p11.2) in Philadelphia chromosome-negative cells in a patient with chronic myeloid leukemia.
    Medeiros BC; Markovic V; Kamel-Reid S; Lipton JH
    Cancer Genet Cytogenet; 2007 Feb; 173(1):83-4. PubMed ID: 17284377
    [No Abstract]   [Full Text] [Related]  

  • 32. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
    Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM
    Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone marrow derived mesenchymal stem cells from chronic myeloid leukemia t(9;22) patients are devoid of Philadelphia chromosome and support cord blood stem cell expansion.
    Jootar S; Pornprasertsud N; Petvises S; Rerkamnuaychoke B; Disthabanchong S; Pakakasama S; Ungkanont A; Hongeng S
    Leuk Res; 2006 Dec; 30(12):1493-8. PubMed ID: 16839603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Chronic myeloid leukemia, biological aspects].
    Costello R; Bouabdallah R; Sainty D; Gastaut JA; Gabert J
    Rev Med Interne; 1996; 17(3):213-23. PubMed ID: 8734143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Application of fluorescence in situ hybridization technique in diagnosis of variant Ph chromosome translocation and Ph-negative chronic myelocytic leukemia].
    Jing Y; Jiang F; Lin S; Wang FT; Fang MY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Oct; 27(5):563-6. PubMed ID: 20931538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clonal evolution with double Ph followed by tetraploidy in imatinib-treated chronic myeloid leukemia with e19a2 transcript in transformation.
    Oshikawa G; Kurosu T; Arai A; Murakami N; Miura O
    Cancer Genet Cytogenet; 2010 May; 199(1):56-61. PubMed ID: 20417871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Masked Philadelphia chromosome due to atypical BCR/ABL localization on the 9q34 band and duplication of the der(9) in a case of chronic myelogenous leukemia.
    Fugazza G; Garuti A; Marchelli S; Miglino M; Bruzzone R; Gatti AM; Castello S; Sessarego M
    Cancer Genet Cytogenet; 2005 Dec; 163(2):173-5. PubMed ID: 16337863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Technical aspects and clinical applications of measuring BCR-ABL1 transcripts number in chronic myeloid leukemia.
    Foroni L; Gerrard G; Nna E; Khorashad JS; Stevens D; Swale B; Milojkovic D; Reid A; Goldman J; Marin D
    Am J Hematol; 2009 Aug; 84(8):517-22. PubMed ID: 19544476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patterns of BCR/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in BCR/ABL+ leukemias: incidence and underlying genetic abnormalities.
    Primo D; Tabernero MD; Rasillo A; Sayagués JM; Espinosa AB; Chillón MC; Garcia-Sanz R; Gutierrez N; Giralt M; Hagemeijer A; San Miguel JF; Orfao A
    Leukemia; 2003 Jun; 17(6):1124-9. PubMed ID: 12764379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genomic deletions on other chromosomes involved in variant t(9;22) chronic myeloid leukemia cases.
    Albano F; Specchia G; Anelli L; Zagaria A; Storlazzi CT; Buquicchio C; Roberti MG; Liso V; Rocchi M
    Genes Chromosomes Cancer; 2003 Apr; 36(4):353-60. PubMed ID: 12619159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.